Print

AVEG 004

Trial Details:

I Completed
National Institute of Allergy and Infectious Diseases (NIAID) December 13, 1990
gp160 Vaccine (Immuno-AG) Protein gp160 env B LAI, MN
gp160 Vaccine (Immuno-AG) Protein
USA 60
NCT00000968
http://clinicaltrials.gov/ct2/show/NCT00000968